Confirmation knockdown studies of CDKL3, HIPK4, MAP3K7, and RET were conducted using parental T24T cells, which harbor the heterozygous −124 promoter mutation and display higher hTERT mRNA compared to other BLCA cell lines (Figure 5B–E) [30]. The gene discussed is CDKL3; the disease is bladder transitional cell carcinoma.